Dr. Alexander M. Stessin
Claim this profileStony Brook University Medical Center
Studies Breast Cancer
Studies Glioblastoma
5 reported clinical trials
11 drugs studied
Area of expertise
1Breast Cancer
Stage II
Stage I
HER2 negative
2Glioblastoma
Stage IV
Affiliated Hospitals
Clinical Trials Alexander M. Stessin is currently running
Atezolizumab + Radiation
for Glioblastoma
This is a single-arm pilot study that will recruit 12 patients with newly diagnosed Glioblastoma, a malignant brain tumor with a poor prognosis. Patients will be treated with fractionated stereotactic radiotherapy (FSRT) for 2 weeks, in addition to two doses of Atezolizumab (Tecentriq), an FDA approved PD- L1 inhibitor drug, 840 mg IV, at the beginning and at the end of the two-week time period, concomitantly with FSRT. After this initial two weeks treatment the patients will undergo craniotomy and maximal safe resection as per normal care for a GB. After surgery patients will follow the normal care for glioblastoma in addition to Atezolizumab 840 mg IV q2 weeks for the duration of adjuvant treatment.
Recruiting2 awards Phase < 1
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
More about Alexander M. Stessin
Clinical Trial Related2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Alexander M. Stessin has experience with
- Radiation
- Stereotactic Body Radiation Therapy (SBRT)
- Atezolizumab
- FSRT Radiation
- No Radiation
- Anastrozol
Breakdown of trials Alexander M. Stessin has run
Breast Cancer
Glioblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alexander M. Stessin specialize in?
Alexander M. Stessin focuses on Breast Cancer and Glioblastoma. In particular, much of their work with Breast Cancer has involved Stage II patients, or patients who are Stage I.
Is Alexander M. Stessin currently recruiting for clinical trials?
Yes, Alexander M. Stessin is currently recruiting for 4 clinical trials in Stony Brook New York. If you're interested in participating, you should apply.
Are there any treatments that Alexander M. Stessin has studied deeply?
Yes, Alexander M. Stessin has studied treatments such as Radiation, Stereotactic Body Radiation Therapy (SBRT), Atezolizumab.
What is the best way to schedule an appointment with Alexander M. Stessin?
Apply for one of the trials that Alexander M. Stessin is conducting.
What is the office address of Alexander M. Stessin?
The office of Alexander M. Stessin is located at: Stony Brook University Medical Center, Stony Brook, New York 11794 United States. This is the address for their practice at the Stony Brook University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.